Tarsus Pharmaceuticals, Inc. ($TARS)
Filing Information
| Accession Number | 0001842190-26-000009 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 3, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
11,578
Total Value
$897,989.86
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Sep 1, 2026 | Sale | 4,601 | $73.86 | $339,829.86 | 18,707 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Sep 2, 2026 | Sale | 5,387 | $80.00 | $430,960.00 | 13,320 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Sep 2, 2026 | Sale | 1,590 | $80.00 | $127,200.00 | 4,770 | Indirect | By Spouse's Roth IRA | View Details |